Novartis to review $600m global media business
By Katherine Levy, campaignlive.co.uk, Wednesday, 13 April 2011 08:47AM
Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated $600m global media business.
WPP's MEC is the incumbent on the global business, including in the UK.
In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.
The company, which has a consumer health business that markets over the counter medicines such as Tixylix and Savlon, spent £9m in the UK in the past 12 months, according to Nielsen.
Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.
This article was first published on campaignlive.co.uk
- CREATIVE DIRECTORS Live Recruitment Negotiable, England
- DIGITAL DESIGNER - DIGITAL AGENCY Live Recruitment £23000 - £28000 per annum + BENS, Surrey
- GRAPHIC DESIGNER - AGENCY Live Recruitment £NEG + BENEFITS, Hertfordshire
- DESIGNER - AGENCY Live Recruitment DEPENDING ON EXPERIENCE, North West England
- DESIGNERS - DIGITAL, INTEGRATED AND PRINT Live Recruitment £competitive, West Midlands
- Land Rover to move global ad account into Spark44
- Martin Sorrell talks Maurice Lévy, Tesco, and the global outlook
- Viacom to bring Breaking Bad to Freeview with Spike launch
- 'Advertisers are snake oil salesmen', says Peter Oborne
- Group M retains £80m Lloyds media
- WPP's Martin Sorrell reconsiders strength of newspapers